Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
- Source: inbox/queue/2026-05-05-npr-glp1-eating-disorders-not-well-understood.md - Domain: health - Claims: 2, Entities: 0 - Enrichments: 4 - Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5) Pentagon-Agent: Vida <PIPELINE>
19 lines
2.3 KiB
Markdown
19 lines
2.3 KiB
Markdown
---
|
|
type: claim
|
|
domain: health
|
|
description: Atypical anorexics meet full diagnostic criteria for anorexia nervosa despite normal or elevated BMI, making them appear as ideal GLP-1 candidates to prescribers using weight-based screening alone
|
|
confidence: experimental
|
|
source: Dr. Kim Dennis (eating disorder specialist), NPR investigation
|
|
created: 2026-05-05
|
|
title: GLP-1 prescribing creates systematic risk for atypical anorexia patients because BMI-based eligibility screening cannot detect restrictive psychopathology in overweight individuals
|
|
agent: vida
|
|
sourced_from: health/2026-05-05-npr-glp1-eating-disorders-not-well-understood.md
|
|
scope: structural
|
|
sourcer: "NPR (@NPRHealth)"
|
|
supports: ["glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive"]
|
|
related: ["glp1-eating-disorder-screening-gap-structural-capacity-not-clinical-knowledge", "glp1-pre-treatment-eating-disorder-screening-recommended-not-required", "glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive", "glp1-social-media-cosmetic-misuse-creates-eating-disorder-pathway", "glp1-anorexia-nervosa-evidence-absent-despite-pharmacovigilance-signal"]
|
|
---
|
|
|
|
# GLP-1 prescribing creates systematic risk for atypical anorexia patients because BMI-based eligibility screening cannot detect restrictive psychopathology in overweight individuals
|
|
|
|
Dr. Kim Dennis identifies a structural screening gap: patients with atypical anorexia nervosa meet full diagnostic criteria for restrictive eating disorders despite having normal or elevated BMI. To a prescriber using standard weight-based eligibility criteria, these patients appear as ideal GLP-1 candidates—overweight individuals seeking medically supervised weight loss. However, they have active restrictive psychopathology that GLP-1s would amplify. The NPR piece quotes Dennis specifically raising concern for 'atypical anorexics' who 'appear like ideal GLP-1 candidates to an unaware prescriber.' This creates a population-specific harm pathway that standard BMI screening cannot detect. The mechanism is invisibility: the very criterion that makes someone eligible (elevated BMI) masks the psychological contraindication (active restriction). This is distinct from general eating disorder risk—it's a specific population where the eligibility criterion and the risk factor are structurally confounded.
|